OptimizeRx to Participate at Investor Conferences in November
OptimizeRx Corp. (Nasdaq: OPRX), a leader in digital health solutions, will participate in two investor conferences in November 2020. The events are the Roth Technology Virtual Conference on November 11 and the Stifel Midwest One-on-One Growth Conference on November 12. Management will engage in one-on-one meetings with institutional investors to discuss the company’s anticipated record revenue exceeding $10 million for Q3 2020, representing over 100% year-over-year growth. This growth stems from strong enterprise deals and programs enhancing value for life science customers.
- None.
- None.
ROCHESTER, Mich., Oct. 20, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited to participate in two investor conferences being held in November.
Event: ROTH Technology Virtual Conference
Attendance Date: November 11, 2020
Format: Virtual 1x1 and small group meetings
Registration: Email registration@roth.com or click here.
Event: Stifel Midwest One-on-One Growth Conference
Attendance Date: November 12, 2020
Format: Virtual 1x1 meetings
Registration: Please contact your Stifel institutional sales representative.
OptimizeRx management is scheduled to participate in virtual one-on-one meetings with institutional investors and analysts at both conferences.
Management will discuss the company’s recently reported preliminary results for the third quarter of 2020. The company expects record revenue of more than
They will review how this growth is being driven organically by a combination of enterprise deals and tactical programs, as its life science customers increasingly see the value in transparent access to physicians and patients via the OptimizeRx digital health platform.
To schedule a virtual one-on-one meeting with OptimizeRx, you may submit your request via the links provided upon your registration for the conferences. For any questions about the company, please contact Ron Both of CMA at (949) 432-7557 or submit your request here.
About Roth Capital Partners
ROTH Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, ROTH provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access. Headquartered in Newport Beach, CA, ROTH is privately-held and employee owned, and maintains offices throughout the U.S. For more information on ROTH, please visit www.roth.com.
About Stifel
Stifel is a full-service investment firm with a distinguished history of providing securities brokerage, investment banking, trading, investment advisory, and related financial services to individual investors, institutions, corporations, and municipalities. Established in 1890 and headquartered in St. Louis, Missouri, Stifel is one of the nation’s leading firms.
For more information about Stifel, visit www.stifel.com.
About OptimizeRx
OptimizeRx is a digital health company that provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcare providers in the U.S. and millions of patients through a proprietary network, the OptimizeRx digital health platform helps patients afford and stay on medications. The platform unlocks new patient and physician touchpoints for life science companies along the patient journey, from point-of-care, to retail pharmacy, through mobile patient engagement.
For more information, follow the company on Twitter, LinkedIn or visit www.optimizerx.com.
Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
OptimizeRx Contact
Doug Baker, CFO
Tel (248) 651-6568 (x807)
dbaker@optimizerx.com
Media Relations Contact
Maira Alejandra, Media Relations Manager
Tel (754) 245-7070
malejandra@optimizerx.com
Investor Relations Contact
Ron Both, CMA
Tel (949) 432-7557
oprx@cma.team
FAQ
What are the investor conferences OptimizeRx will attend in November 2020?
What revenue growth is OptimizeRx expecting for Q3 2020?
How can investors schedule meetings with OptimizeRx management during the conferences?
What is the primary focus of the discussions at the investor conferences?
